Galectins in cancer: carcinogenesis, diagnosis and therapy

A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on th...

Full description

Saved in:
Bibliographic Details
Published inAnnals of translational medicine Vol. 2; no. 9; p. 88
Main Authors Ebrahim, Ali Hasan, Alalawi, Zainab, Mirandola, Leonardo, Rakhshanda, Rahman, Dahlbeck, Scott, Nguyen, Diane, Jenkins, Marjorie, Grizzi, Fabio, Cobos, Everardo, Figueroa, Jose A, Chiriva-Internati, Maurizio
Format Journal Article
LanguageEnglish
Published China AME Publishing Company 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on the unique role played by the galectin family of proteins in neoplasia, and how this knowledge may alter the approach to cancer diagnosis as well as therapy in the future. In this review we have also emphasized the potential use of galectin inhibitors or modulators in the treatment of cancer and how this novel treatment modality may affect patient outcomes in the future. Based on current pre-clinical models we believe the use of galectin inhibitors/modulators will play a significant role in cancer treatment in the future. Early clinical studies are underway to evaluate the utility of these promising agents in cancer patients.
AbstractList A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on the unique role played by the galectin family of proteins in neoplasia, and how this knowledge may alter the approach to cancer diagnosis as well as therapy in the future. In this review we have also emphasized the potential use of galectin inhibitors or modulators in the treatment of cancer and how this novel treatment modality may affect patient outcomes in the future. Based on current pre-clinical models we believe the use of galectin inhibitors/modulators will play a significant role in cancer treatment in the future. Early clinical studies are underway to evaluate the utility of these promising agents in cancer patients.
Author Rakhshanda, Rahman
Jenkins, Marjorie
Grizzi, Fabio
Ebrahim, Ali Hasan
Nguyen, Diane
Cobos, Everardo
Dahlbeck, Scott
Figueroa, Jose A
Alalawi, Zainab
Chiriva-Internati, Maurizio
Mirandola, Leonardo
Author_xml – sequence: 1
  givenname: Ali Hasan
  surname: Ebrahim
  fullname: Ebrahim, Ali Hasan
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 2
  givenname: Zainab
  surname: Alalawi
  fullname: Alalawi, Zainab
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 3
  givenname: Leonardo
  surname: Mirandola
  fullname: Mirandola, Leonardo
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 4
  givenname: Rahman
  surname: Rakhshanda
  fullname: Rakhshanda, Rahman
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 5
  givenname: Scott
  surname: Dahlbeck
  fullname: Dahlbeck, Scott
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 6
  givenname: Diane
  surname: Nguyen
  fullname: Nguyen, Diane
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 7
  givenname: Marjorie
  surname: Jenkins
  fullname: Jenkins, Marjorie
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 8
  givenname: Fabio
  surname: Grizzi
  fullname: Grizzi, Fabio
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 9
  givenname: Everardo
  surname: Cobos
  fullname: Cobos, Everardo
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 10
  givenname: Jose A
  surname: Figueroa
  fullname: Figueroa, Jose A
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
– sequence: 11
  givenname: Maurizio
  surname: Chiriva-Internati
  fullname: Chiriva-Internati, Maurizio
  organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25405163$$D View this record in MEDLINE/PubMed
BookMark eNpVkE9LAzEQxYMottZ-BVnw4sGuk2T_JD0IUrQKBS96XmazkzZlm62brdBv74K11NN7vBl-D94VO_eNJ8ZuOcRS5-phHbsQfCwkpJNUSR0L4EkMOubijA2P8fmJH7BxCGsA4IJrCXDJBiJNIOWZHLLpHGsynfMhcj4y6A21015b43yzJE_Bhfuocrj0TW8j9FXUrajF7f6aXVisA40POmKfL88fs9fJ4n3-NntaTIwUSTdRRoCxlmwCyJUqK425MRlUucpLBUhCc5Rk0VpMhZCp1FharbTOywyVlSP2-Mvd7soNVYZ812JdbFu3wXZfNOiK_xfvVsWy-S4SAanKVA-4OwDa5mtHoSs2Lhiqa_TU7ELBM5HxLElA9K83p13Hkr_B5A-mC3Qn
CitedBy_id crossref_primary_10_1007_s11696_021_02026_7
crossref_primary_10_3389_fgene_2023_1122864
crossref_primary_10_1021_acs_biomac_9b01370
crossref_primary_10_1186_s13046_021_02095_2
crossref_primary_10_1186_s13048_021_00874_1
crossref_primary_10_3390_ijms22116000
crossref_primary_10_1007_s11248_021_00276_5
crossref_primary_10_3389_fcvm_2023_1052959
crossref_primary_10_3389_fonc_2021_706862
crossref_primary_10_3390_ijms23126414
crossref_primary_10_3390_cancers13194819
crossref_primary_10_5483_BMBRep_2020_53_4_020
crossref_primary_10_18786_2072_0505_2024_52_006
crossref_primary_10_3389_fimmu_2024_1352454
crossref_primary_10_3389_fonc_2021_809170
crossref_primary_10_3390_molecules25215121
crossref_primary_10_4132_jptm_2015_02_25
crossref_primary_10_3390_jcm10153313
crossref_primary_10_3389_fendo_2023_1124111
ContentType Journal Article
Copyright 2014 Annals of Translational Medicine. All rights reserved. 2014 Annals of Translational Medicine.
Copyright_xml – notice: 2014 Annals of Translational Medicine. All rights reserved. 2014 Annals of Translational Medicine.
DBID NPM
7X8
5PM
DOI 10.3978/j.issn.2305-5839.2014.09.12
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2305-5839
EndPage 88
ExternalDocumentID 25405163
Genre Journal Article
Review
GroupedDBID 53G
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
HYE
M~E
NPM
OK1
RPM
7X8
5PM
ID FETCH-LOGICAL-c324t-8c20cffef40a188bd9a7cc60d787b80ae291a3efaffa5223539abf98997b6a8f3
IEDL.DBID RPM
ISSN 2305-5839
IngestDate Fri Sep 01 02:35:41 EDT 2023
Thu Apr 11 15:46:10 EDT 2024
Thu May 23 23:19:54 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 9
Keywords galectins
solid tumors
lectins
Cancer
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c324t-8c20cffef40a188bd9a7cc60d787b80ae291a3efaffa5223539abf98997b6a8f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
These authors contributed equally for the first authorship.
These authors contributed equally for the senior authorship.
PMID 25405163
PQID 1626164402
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205868
proquest_miscellaneous_1626164402
pubmed_primary_25405163
PublicationCentury 2000
PublicationDate 2014-Sep
20140901
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-Sep
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Annals of translational medicine
PublicationTitleAlternate Ann Transl Med
PublicationYear 2014
Publisher AME Publishing Company
Publisher_xml – name: AME Publishing Company
References 21958686 - J Exp Clin Cancer Res. 2011 Sep 29;30:89
24939371 - Glycobiology. 2014 Oct;24(10):899-906
18264727 - J Cancer Res Clin Oncol. 2008 Aug;134(8):899-907
20382700 - Am J Pathol. 2010 Jun;176(6):3023-31
19286570 - Am J Pathol. 2009 Apr;174(4):1515-23
24560493 - Lung Cancer. 2014 Apr;84(1):73-8
23389289 - Carcinogenesis. 2013 Jun;34(6):1370-81
24281352 - Mol Biosyst. 2014 Feb;10(2):258-65
18319555 - J Med Invest. 2008 Feb;55(1-2):127-32
21949569 - World J Biol Chem. 2011 Sep 26;2(9):193-201
23179497 - J Neurooncol. 2013 Jan;111(2):123-32
12727847 - Cancer Res. 2003 May 1;63(9):2251-5
20363921 - Am J Pathol. 2010 May;176(5):2067-81
22986745 - Cancer Res. 2012 Nov 15;72(22):5757-66
23985992 - Oncotarget. 2013 Sep;4(9):1461-71
23929302 - Int J Cancer. 2014 Feb 15;134(4):873-84
23824659 - PLoS One. 2013 Jun 18;8(6):e65957
22237208 - Cell Death Dis. 2012 Jan 12;3:e251
22622427 - J Invest Dermatol. 2012 Sep;132(9):2245-54
22696230 - Clin Cancer Res. 2012 Aug 1;18(15):4037-47
15487449 - Am J Clin Pathol. 2004 Oct;122(4):524-31
23917726 - Cancer Biol Ther. 2013 Oct 1;14(10):897-906
22900040 - PLoS One. 2012;7(8):e42699
24139517 - Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):975-82
20592339 - Anticancer Res. 2010 May;30(5):1547-52
20162566 - Int J Cancer. 2010 Dec 1;127(11):2530-41
25189484 - Clin Cancer Res. 2014 Nov 1;20(21):5558-69
22939954 - Hum Pathol. 2013 Jan;44(1):62-8
15837748 - Clin Cancer Res. 2005 Apr 15;11(8):2962-8
18313712 - Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83
24511119 - J Am Soc Nephrol. 2014 Jul;25(7):1486-95
22892876 - World J Urol. 2013 Apr;31(2):351-8
8063692 - J Biol Chem. 1994 Aug 19;269(33):20807-10
20546628 - BMC Cancer. 2010 Jun 15;10:290
23643871 - Gynecol Oncol. 2013 Dec;131(3):645-9
21933892 - Clin Cancer Res. 2011 Nov 15;17(22):7035-46
24339976 - PLoS One. 2013 Dec 10;8(12):e81883
19818782 - Gastroenterology. 2010 Mar;138(3):1035-45.e1-2
23204230 - Cancer Res. 2013 Feb 1;73(3):1107-17
22513979 - J Pathol. 2012 Sep;228(1):56-66
21350102 - Am J Clin Pathol. 2011 Mar;135(3):454-60
16112008 - Hum Pathol. 2005 Aug;36(8):908-14
20299755 - J Med Invest. 2010 Feb;57(1-2):152-7
9988230 - Int J Cancer. 1999 Feb 19;84(1):39-43
23967302 - PLoS One. 2013 Aug 14;8(8):e72468
22291012 - J Biol Chem. 2012 Mar 23;287(13):9753-64
23015305 - J Gastroenterol. 2013 Mar;48(3):350-9
References_xml
SSID ssj0001219300
Score 2.277951
SecondaryResourceType review_article
Snippet A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 88
SubjectTerms Highlighted Reports in Galectins
Title Galectins in cancer: carcinogenesis, diagnosis and therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/25405163
https://search.proquest.com/docview/1626164402
https://pubmed.ncbi.nlm.nih.gov/PMC4205868
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT8IwGG2Qg_FiNP7CX5nRo4N13daWmyEiMcF4kITb0natzkghDA7-937dGAG9edkOXZPl-9ruve59rwjdRcZIKbH2oyxM4EJiX2JpfK61JlRmiQ5cvfPwJRmMoudxPG6guK6FKUX7SuZt-zVp2_yj1FbOJqpT68Q6r8NeFAYxS1hnB-1QQjYoerWxApikLD0BdB27qiK-i24dOwXC1Pks51Z73eTEXaXTKXbn2oQOv2BnCfoXbv5WTW58hvoHaH-FH72H6j0PUUPbI9R9Em73PbeFl1tPuUTOu3Cfq9xO391qlhf3Xlap6vLCEzbzqsKr72M06j--9Qb-6lAEXwH2WfhMhYEyRpsoEJgxmXFBlUqCDGaeZIHQIceCaCOMEYCtSEy4kIYDraIyEcyQE9S0U6vPkEdZBgAIqwwgYMSDWNDIuYFxbIyh1IgWuqmjkMKgc38ShNXTZZFioEHAs4B7ttBpFZV0VrljpHUMW4huxWv9gDO03m6BPJfG1qu8nv-75wXac_msNGCXqLmYL_UVgIaFvC4HyQ-vysH_
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25TsQwEB1xSEDDIa7lDIKSHM7lhA4hYDkWUbCILrIdGwKsF-1RwNczTjYIlgqapHBSeDxO3rPfPAMchEpxzom0w9yP8RJENidc2amUMqA8j6Vn6p1bN3GzHV4-RA8TENW1MKVoX_DC0a8dRxdPpbbyrSPcWifm3rZOQt-LkjhxJ2Ea56tPv5H0amkFUUlZfIL4OjJ1RekM7Bt-ipTJfS5nl_PVZORdpdcpMSfb-AbBEGMK-htwjusmv_2Izhbgvu5CpT95cYYD7oiPMXfHP_dxEeZH0NQ6rpqXYELqZTg6Z2Zhv9B9q9CWMDnSO8J7TxS6-2g-lEX_0MorwV7Rt5jOraqm630F2mendydNe3Tegi0QVg3sRPieUEqq0GMkSXieMipE7OU4qXniMemnhAVSMaUYwrYgClLGVYqMjfKYJSpYhSnd1XIdLJrkiK2IyBFdhqkXMRoao7GUKKUoVawBe3V4M8xns0nBtOwO-xlBhoUUDmltA9aqcGdvlfFGVg9OA-iPgfh6wHhl_2zB8Jae2aNwbvz7zV2Ybd61rrPri5urTZgzSVNJzbZgatAbym3EJgO-U2biJyHy4_g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25TsQwEB1xSIiGQ1zLGQQlOZzbdAhYbkQBEqKJfEKA9a72KODrGSe7aIGOJinsFB6Pk_ecN88A-7HWnHOi3FiGKV6ixOWEa5cqpaKMy1QFtt755jY9f4gvH5PHsaO-KtG-4KVn3lueKV8qbWWnJfyRTsy_uzmOwyDJ09zvSO1PwjSu2ZCOEfV6ewWRSVWAghg7sbVFdAb2LEdF2uS_VivM-26yEq_K75TY021Ci2KINQb9Czp_ayfHPkbNeXgaDaPWoLx5gz73xOcvh8d_jXMB5oYQ1TmquyzChDJLcHjG7AZ_aXpOaRxhc6V7iPeuKE372b4wy96BI2vhXtlzmJFOXdv1sQwPzdP743N3eO6CKxBe9d1chIHQWuk4YCTPuaQsEyINJC5ungdMhZSwSGmmNUP4FiURZVxTZG4ZT1muoxWYMm2j1sDJcokYiwiJKDOmQcKy2BqOUaK1zjLNGrA7CnGBeW1_VjCj2oNeQZBpIZVDetuA1TrkRac24ChGE9SA7MdkfHewntk_WzDElXf2MKTr_35yB2buTprF9cXt1QbM2rypFWebMNXvDtQWQpQ-366S8QtaVOZ4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Galectins+in+cancer%3A+carcinogenesis%2C+diagnosis+and+therapy&rft.jtitle=Annals+of+translational+medicine&rft.au=Ebrahim%2C+Ali+Hasan&rft.au=Alalawi%2C+Zainab&rft.au=Mirandola%2C+Leonardo&rft.au=Rakhshanda%2C+Rahman&rft.date=2014-09-01&rft.pub=AME+Publishing+Company&rft.issn=2305-5839&rft.eissn=2305-5839&rft.volume=2&rft.issue=9&rft_id=info:doi/10.3978%2Fj.issn.2305-5839.2014.09.12&rft_id=info%3Apmid%2F25405163&rft.externalDBID=PMC4205868
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2305-5839&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2305-5839&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2305-5839&client=summon